Direct link between mhc polymorphism, T cell avidity, and diversity in immune defense

Science

Volumn 298, Issue 5599, 2002, Pages 1797-1800

  Messaoudi, Ilhem ^a,b   Guevara Patiño, Jose A ^b   Dyall, Ruben ^b   LeMaoult, Joël ^b   Nikolich Žugich, Janko ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENS; CELLS; GENES; PATHOLOGY;

ANTIVIRAL DEFENSE; POLYMORPHISM;

IMMUNOLOGY;

GENE; IMMUNE RESPONSE; POLYMORPHISM;

ANIMAL CELL; ANTIGEN PRESENTATION; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DOSE RESPONSE; GENETIC CODE; GENETIC POLYMORPHISM; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR RECOGNITION; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADOPTIVE TRANSFER; ANIMALS; COMPLEMENTARITY DETERMINING REGIONS; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GENES, MHC CLASS I; H-2 ANTIGENS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; IMMUNITY, NATURAL; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; POLYMORPHISM, GENETIC; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES, CYTOTOXIC;

ANIMALIA; HUMAN HERPESVIRUS 1; RNA VIRUSES; SIMPLEXVIRUS;

EID: 2242419092     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1076064     Document Type: Article

References (35)

1. R. N. Germain, D. H. Margulies, Annu. Rev. Immunol. 11, 403 (1993).
2. P. J. Fink, M. J. Bevan, Adv. Immunol. 59, 99 (1995).
3. D. A. Lawlor, J. Zemmour, P. D. Ennis, P. Parham, Annu. Rev. Immunol. 8, 23 (1990).
4. W. K. Potts, P. R. Slev, Immunol. Rev. 143, 181 (1995).
5. J. Kaufman, H. Volk, H.-J. Wallny, Immunol. Rev. 143, 64 (1995).
6. A. V. S. Hill et al., Nature 352, 595 (1988).
7. S. G. Nathenson, J. Geliebter, G. M. Pfaffenbacb, R. A. Zeff, Annu. Rev. Immunol. 4, 471 (1986).
8. Single-letter abbreviations for the amino acid residues are as follows: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr.
9. P. J. Bjorkman et al., Nature 329, 512 (1987).
10. R. Dyall, I. Messaoudi, S. Janetzki, J. Nikolich-Žugich, J. Immunol. 164, 1695 (2000).
11. A. A. Nash, P. Cambouropoulos, Semin. Virol. 4, 181 (1993).
12. B. T. Rouse, M. Gierynska, Herpes 8 (Suppl. 1), 2A (2000).
13. Materials and methods are available as supporting material on Science Online.
14. T. Hanke, F. L. Graham, K. L. Rosenthal, D. C. Johnson, J. Virol. 65, 1177 (1991).
15. R. H. Bonneau, L. A. Salvucci, D. C. Johnson, S. S. Tevethia, Virology 195, 62 (1993).
16. S. C. Cose, C. M. Jones, M. E. Wallace, W. R. Heath, F. R. Carbone, Eur. J. Immunol. 27, 2310 (1997).
17. M. E. Wallace, R. Keating, W. R. Heath, F. R. Carbone, J. Virol. 73, 7619 (1999).
18. R. Dyall, D. H. Fremont, S. C. Jameson, J. Nikolich- Zǔgich, J. Exp. Med. 184, 253 (1996).
19. I. Messaoudi et al., J. Immunol. 167, 863 (2001).
20. S. C. Cose, J. M. Kelly, F. R. Carbone, J. Virol. 69, 5849 (1995).
21. S. J. Turner, F. R. Carbone, Mol. Immunol. 35, 307 (1998).
22. A. Hill, et al., Nature 375, 411 (1995).
23. K. Fruh, et al., Nature 375, 425 (1995).
24. K. Goldsmith, W. Chen, D. C. Johnson, R. L. Hendricks, J. Exp. Med. 187, 341 (1998).
25. T. Liu, K. M. Khanna, X.-P. Chen, D. J. Fink, R. L. Hendricks, J. Exp. Med. 191, 1459 (2000).
26. R. Bertoni et al., J. Clin. Invest. 100, 503 (1997).
27. A. McMichael, Cell 93, 673 (1998).
28. S. Ehl, P. Klenerman, P. Aichele, H. Hengartner, R. M. Zinkernagel, Eur. J. Immunol. 27, 3404 (1997).
29. D. Moskophidis, F. Lechner, H. Hengartner, R. M. Zinkernagel, J. Immunol. 152, 4976 (1994).
30. D. E. Speiser, D. Kyburz, U. Stubi, H. Hengartner, R. M. Zinkernagel, J. Immunol. 149, 972 (1992).
31. A. Gallimore, T. Dumrese, H. Hengartner, R. M. Zinkernagel, H. G. Rammensee, J. Exp. Med. 187, 1647 (1998).
32. L. Malherbe et al., Immunity 13, 771 (2000).
33. M. Carrington et al., Science 283, 1748 (1999).
34. D. J. Penn, K. Damjanovich, W. K. Potts, Proc. Natl. Acad. Sci. U.S.A. 99, 11260 (2002).
35. b-Bir-plasmids; J. Yewdell, J. Bennink, and D. Margulies (National Institute of Allergy and Infectious Diseases) for helpful suggestions; D. Sant'Angelo (Memorial Sloan-Kettering Cancer Center, Immunology Program) for critical perusing of the manuscript; and S. Silverstein (Columbia University) for the HVH-1 virus. Supported by U.S. Public Health Service grant CA-86803 from the National Institutes of Health (J.N.-Ž.). Part of this work was completed while I.M. was supported by a predoctoral Cancer Research Institute fellowship at the Weill Graduate School of Medical Sciences of Cornell University.